Congo is gearing up to tackle a deadly mpox outbreak with its first-ever vaccination campaign, launched this week in Goma. Health workers lined up to receive shots in a symbolic ceremony, but officials warn limited resources mean only 265,000 doses are available—just a fraction of what's needed.
Why This Matters
The campaign addresses a glaring gap: in 2022, vaccines were widely accessible in Europe and the U.S. during a global outbreak, but Africa had zero access. Now, Congo is leading the charge to protect its people from the virus, which has already caused 30,000+ cases and 990 deaths this year.
WHO Applauds 'Crucial Step'
WHO Africa Director Matshidiso Moeti praised the rollout, calling it vital for "limiting the virus' spread". Mpox, spread through close contact, causes flu-like symptoms and painful lesions. A new variant triggered a global health emergency alert in August.
A Long Road Ahead
With Congo accounting for 90% of Africa's mpox cases, the stakes are high. More doses are "in the pipeline," but advocates stress that equity in global health responses remains urgent. Stay tuned for updates!
